Biggest News Aggregation in the World
📰 Sarcoma Foundation News

Page 7 - Sarcoma Foundation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Sarcoma Foundation. Real-time updates on events, politics, business and more.

Adaptimmune Therapeutics PLC: Clinical Responses Reported across Patient Subgroups with Adaptimmune's Cell Therapy, Afami-cel, Confirming Potential for People with Rare Sarcomas

- Patients who responded to afami-cel had longer progression-free survival (median 58 weeks) compared to non-responders (median 12 weeks) -- Responses occurred across subgroups, with greater response
United States Brandi Felser Julip Miller Exchange Commission American Society Of Clinical Oncology Sarcoma Foundation Of America

Two-drug combo starves bone cancer cells to death

Starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, according to a new study. Studying human cancer cells and mice, researchers report that a two-drug combination targeting a tumor’s energy sources could prove as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Osteosarcoma is the most comm...
United States Richa Rathore Sarcoma Foundation Of America Siteman Cancer Center At Barnes Washington University Surgical Oncology Training Grant National Institutes Of Health

Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests | The Source

Two drugs targeting cancer cells’ energy source potentially could replace toxic chemo in osteosarcoma January 26, 2021 SHARE A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Shown is a cross section of osteosarcoma. (Image: Richa Rathore) An in...
United States Luminex Flexmap Laura Shelton Richa Rathore School Of Medicine Sarcoma Foundation Of America
Source: wustl.edu

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests

 E-Mail IMAGE: A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumors energy sources could be as effective and less toxic than... view more  Credit: RICHA RATHORE An innovative approach to treating bone tumors - starving cancer cells of the energy they need to grow - could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washingt...
United States Luminex Flexmap Laura Shelton Richa Rathore School Of Medicine Sarcoma Foundation Of America

Breweries come together to honor memory of DC beer fixture

Breweries come together to honor memory of DC beer fixture By Mike Thomas and FOX 5 DC Digital Team Published  WASHINGTON (FOX 5 DC) - Ben Tolken was a fixture in the D.C. beer community for more than a decade, and now that same community is honoring his memory by creating and selling a new brew to raise money for a cause near and dear to their hearts. Breweries come together to honor memory of D.C. beer fixture A group of breweries from across the D.C. area are coming together to create...
United States Ben Tolken Sarcoma Foundation Pizzeria Paradiso Never Ending ஒன்றுபட்டது மாநிலங்களில்
Source: fox5dc.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science